Hcde 333 Presentation
-
Upload
cachualovely20 -
Category
Documents
-
view
221 -
download
0
Transcript of Hcde 333 Presentation
-
7/27/2019 Hcde 333 Presentation
1/26
Toxicology ReportEthinyl Estradiol
Abbi, Anh, Melody and Paul
-
7/27/2019 Hcde 333 Presentation
2/26
Purpose
Know the environmental sources of
ethinyl estradiol Understand the human health effects
connected to ethinyl estradiol
-
7/27/2019 Hcde 333 Presentation
3/26
Overview
1. About Ethinyl Estradiol (EE2)
2. Environmental Sources
3. Health Effects
4. Limitations
5. Conclusion
6. References
-
7/27/2019 Hcde 333 Presentation
4/26
1. About Ethinyl Estradiol (EE2)
Synthetic estrogen hormone
Used in birth control and for hormonal therapies
Birth control dose is usually 20-60 ug daily
Only 50% is absorbed on average in the human body
-
7/27/2019 Hcde 333 Presentation
5/26
1. Environmental Cycle of EE2
-
7/27/2019 Hcde 333 Presentation
6/26
2. Environmental Sources -Overview
Primarily water exposure
Can enter soil and air through water,but likelihood of human contact is slim
and amount would be small
Enters water through sewage
Has been detected at levels up to 273ng/L
Chance of meaningful, unintentionalcontact is minimal
-
7/27/2019 Hcde 333 Presentation
7/26
2.1 Route of Exposure
Oral, through unintentional ingestion
Via water
-
7/27/2019 Hcde 333 Presentation
8/26
2.1.2 How EE2 enters the watera. human sources
Consumed in birth control pills and other hormonaltherapieso Over 60 million women worldwide take birth
control pills
30-90% of compound is not absorbed by the bodyand is then excreted
Based on a 60% excretion rate, ~720kg ethinylestradiol enters the water supply annually
-
7/27/2019 Hcde 333 Presentation
9/26
2.1.2 How EE2 enters the waterb. animal sources
Currently, no known significant animal contributors
Other types of estrogens from animals may present
a concern, but not ethinyl estradiol
If ethinyl estradiol becomes a common compound forlarge-scale animal use, then animal sources would
become a significant contributor of ethinyl estradiolto concentrations in water
-
7/27/2019 Hcde 333 Presentation
10/26
2.1.2 How EE2 enters the waterc. industrial sources
No significant sources documented
However, increased concentrations of other
pharmaceuticals in water sources near productionfacilities have been found
More research is needed
-
7/27/2019 Hcde 333 Presentation
11/26
2.2 Amount of EE2 in water
In a survey of water sources: 0.1 ng/L (belowdetection limit) to 273 ng/L
In raw sewage, generally about 10 ng/Lo has been found in higher concentrations
Eventually biodegrades in water, but"pseudopersistent" in areas where sewage is
continually discharged
-
7/27/2019 Hcde 333 Presentation
12/26
2.3 Removal of EE2 from wastewater
Significant amounts of ethinyl estradiol can beremoved with wastewater treatment
Primary wastewater treatment can remove ~14% of
total estrogen hormones (ethinyl estradiol makes upa small portion of the total)
A type of secondary treatment called activatedsludge can eliminate over 60% of ethinyl estradiol
from wastewater
-
7/27/2019 Hcde 333 Presentation
13/26
2.4 Likelihood of human contactwith environmental EE2
In general, contact with significant amounts unlikely
Drinking water generally not the same source wherewastewater is released
Ethinyl estradiol eventually degrades in water, soassuming that the water will not be immediatelyconsumed, contact with the compound is unlikely
In closed water reuse systems, contact likelihoodincreases due to the reuse of wastewater as drinkingwater
-
7/27/2019 Hcde 333 Presentation
14/26
3. Health Effects Related to EE2
Pharmaceutical Source: Cardiovascular Respiratory Reproductive Death
Genotoxic Carcinogenic Neurological Behavorial
Environmental Source: Immunological Reproductive Developmental
-
7/27/2019 Hcde 333 Presentation
15/26
3.1 Health Effects - Systemic
Cardiovascular
Systemic Hypertension Myocardial Ischemia Myocardial Infarction
(Heart Attack) Thromboembolic Disease(Blood Clot)
Fluid Retention Edema
Respiratory
Pulmonary Hypertension Pulmonary Emboli
(Clot in lung arteries)
-
7/27/2019 Hcde 333 Presentation
16/26
3.2 Health Effects - Immunological
In mammals and fish estrogen including ethinyl estradiolinhibits different part of immune response
Animal studies show immunosupression via decreasinglymphocyte production, especially in male fish exposed
to contaminated effluent.
Studies also indicate that ethinyl estradiol is more potentin mixed concoctions than when administered alone.
-
7/27/2019 Hcde 333 Presentation
17/26
3.3 Health Effects - Reproductive
Oral Contraceptives:o breakthrough vaginal bleedingo glucose intoleranceo breast tenderness
Case Report: male employee of a pharmaceuticalcompany making contraceptive pills containingethinyl estradiol developing prolactin secretingadenoma
Environmental Exposure:oAnimal studies show decline in reproductive
successo Feminization in male fish
3 ff
-
7/27/2019 Hcde 333 Presentation
18/26
3.4 Health Effects - Developmental
Exposure of zebrafish to ethinyl estradiol at a concentration of14-16 ng/L developed ova-testis sex organs.
Relation to humans: Dose is environmentally relavent. Childrenthat grow up with both sex organs have developed genderidentity disorders, depression and dissatisfaction with their
assigned sex. Limitations to data: Fish are very different than humans. There
needs to be studies to correlate ethinyl estradiol exposure tointersex humans.
3 5 H lth Eff t G t i
-
7/27/2019 Hcde 333 Presentation
19/26
3.5 Health Effects - Genotoxic
In the presence of metabolic activation system (S9 mix) withNADP, ethinyl estradiol was found to cause genotoxicdamage to human lymphocytes at 5 and 10 M.o A lymphocyte is a type of white blood cell.o NADP is an important molecule used in cellular respiration to
make energy.o The S9 mix is a mixture of several liver enzymes.
3 6 H lth Eff t C i i
-
7/27/2019 Hcde 333 Presentation
20/26
3.6 Health Effects - Carcinogenic
Women receiving estrogen replacement therapy, includingethinyl estradiol, reported a 2 to 15 fold increase in the riskof endometrial cancer.o Endometrial cancer occurs in the lining of the uterus.
Estrogen replacement therapy uses estrogens to stop theeffects of menopause after the ovaries have been removed
or have stopped functioning.
Limitations to data: Estrogen replacement therapy uses ethinylestradiol as well as a variety of other estrogens. More research isneeded on only ethinyl estradiol for estrogen replacement
therapy.
-
7/27/2019 Hcde 333 Presentation
21/26
-
7/27/2019 Hcde 333 Presentation
22/26
-
7/27/2019 Hcde 333 Presentation
23/26
3.9 Health Effects - Death
No data found for human death but death can occurfrom secondary complications.
No death in animal studies using fish
Death in studies using rats and mices with an LD50 of2952 mg/kg in rats and 1737 mg/kg in mice
4 Li it ti f R f &
-
7/27/2019 Hcde 333 Presentation
24/26
4. Limitations of References &Existing Data
Not enough human studies dealing with environmentalexposure
Not even that many mammal studies...
Limited to primarily to discussion of sewage treatment,no real discussions of ambient concentrations indrinking water sources
5 C l i
-
7/27/2019 Hcde 333 Presentation
25/26
5. Conclusion
More research is needed about the health effectsrelated to ethinyl estradiol and the concentrationsfound in drinking water sources
More research is needed to address ethinyl estradiolas a single substance rather than estrogen mixed Current data does not suggest that ethinyl estradiol in
water presents a great threat to human health
6 R f
-
7/27/2019 Hcde 333 Presentation
26/26
6. References
Andersen H, Siegrist H, Halling-Sorensen B, Ternes TA (2003) Fate of estrogensin a municipal sewage treatment plant. Environ Sci Technol 37:40214026.
Combalbert, S., & Hernandez-Raquet, G. (May 01, 2010). Occurrence, fate, andbiodegradation of estrogens in sewage and manure.Applied Microbiology andBiotechnology, 86, 6, 1671-1692.
Combined Estrogen-Progestogen Contraceptives and CombinedEstrogen-Progestogen Menopausal Therapy. IARC Monographs on theEvaluation of Carcinogenic Risks to Humans, 91. (2007)
Pub Chem. (n.d.). Substance Summary. In Ethinyl Estradiol. Retrieved February20, 2011, fromhttp://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=9737&viewopt =DepositedSiddique, Y.H, Beg, T, & Afzal,. (2010). Genotoxic potential of ethinylestradiol incultured mammalian cells. Chemico-Biological Interactions,151 (5), 133-141.Slone, D., Shapiro, S., Kaufman, D. W., Rosenberg, L., Miettinen, O. S., & Stolley,P. D. (January 01, 1981). Risk of myocardial infarction in relation to current and
discontinued use of oral contraceptives. The New England Journal of Medicine,305, 8, 420-4.Steinberg K.K. (1991) A meta-analysis of the effect of estrogen replacementtherapy on the risk of breast cancer. JAMA. 265:1985-1990.National Library of Medicine. (n.d.). Hazardous Substance Data Bank. InEthinylestradiol. Retrieved February 20, 2011, from http://toxnet.nlm.nih.gov/cgi-
bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6.
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=9737&viewopthttp://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=9737&viewopthttp://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-63-6http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=9737&viewopthttp://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=9737&viewopt